United States· US:0264-9577_be724659-682a-48b4-bcc0-01be11d8b6e9
Heparin Sodium in Dextrose
A medicinal product containing heparin sodium; dextrose monohydrate, registered in United States by B. Braun Medical Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- HEPARIN SODIUM; DEXTROSE MONOHYDRATE
- Manufacturer
- B. Braun Medical Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11026495771024 CONTAINER in 1 CASE (0264-9577-10) / 500 mL in 1 CONTAINER
- ndc110264-9577-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d9adcc93-a562-4406-9eff-78e096aeee7d GET /v1/drugs/d9adcc93-a562-4406-9eff-78e096aeee7d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "5000; 5",
"substance": "HEPARIN SODIUM; DEXTROSE MONOHYDRATE",
"productndc": "0264-9577",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "[USP'U]/100mL; g/100mL",
"application_number": "NDA019952",
"marketing_category": "NDA"
}See everything about heparin sodium; dextrose monohydrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.